Viewing Study NCT01127893


Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-02-10 @ 4:15 AM
Study NCT ID: NCT01127893
Status: TERMINATED
Last Update Posted: 2021-03-10
First Post: 2010-05-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis
Sponsor: Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoarthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Musculoskeletal Diseases View
None Joint Diseases View
None Arthritis View
None Rheumatic Diseases View